SCHEMBL2177942

SCHEMBL2177942

CNc1nccc(-c2cc(NCCCNc3ncnc4[nH]nc(Br)c34)c3cc(OC)ccc3c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.36
DYRK1A Q13627 4/20 0.34
CLK4 Q9HAZ1 4/20 0.34
DYRK1B Q9Y463 3/20 0.34
CLK1 P49759 3/20 0.34
HTR1A P08908 3/20 0.34
ADRA1D P25100 3/20 0.34
ADRA1A P35348 3/20 0.34
ADRA1B P35368 3/20 0.34
CLK2 P49760 2/20 0.34
SYK P43405 3/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PIK3CA P42336 1/20 0.33
HDAC3 O15379 1/20 0.32
NCOR1 O75376 1/20 0.32
HDAC2 Q92769 1/20 0.32
MAPK13 O15264 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2177838 0.80 FERMT2 (0.44) DYRK1ACLK4DYRK1BCLK1HTR1A
SCHEMBL2178230 0.80 HTR1A (0.43) DYRK1ACLK4DYRK1BCLK1HTR1A
SCHEMBL2177950 0.80 PDPK1 (0.34) PDPK1DYRK1ACLK4DYRK1BCLK1
SCHEMBL2180520 0.78 EIF2AK2 (0.37) PDPK1
SCHEMBL2177415 0.77 HTR1A (0.40) DYRK1ACLK4DYRK1BCLK1HTR1A
SCHEMBL2178372 0.77 RPS6KB1 (0.37) PDPK1
SCHEMBL2178497 0.77 HRH4 (0.38)
SCHEMBL2176324 0.76 MKNK1 (0.43) DYRK1ACLK4DYRK1BCLK1HTR1A
SCHEMBL2176538 0.74 HTR1A (0.38) PDPK1DYRK1ACLK4DYRK1BCLK1
SCHEMBL2176544 0.74 HTR1A (0.37) PDPK1DYRK1ACLK4DYRK1BCLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP PDPK1 455/4885DYRK1A 2574/4885CLK4 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.